|
GDI2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.89490999999986E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.4454000047136E-08 |
| Normal-vs-Stage2 |
5.706400E-02 |
| Normal-vs-Stage3 |
2.911800E-01 |
| Normal-vs-Stage4 |
1.333780E-01 |
| Stage1-vs-Stage2 |
2.944000E-01 |
| Stage1-vs-Stage3 |
1.439010E-03 |
| Stage1-vs-Stage4 |
7.196800E-01 |
| Stage2-vs-Stage3 |
2.684800E-01 |
| Stage2-vs-Stage4 |
8.292000E-01 |
| Stage3-vs-Stage4 |
3.260400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.50560000000688E-06 |
| Normal-vs-AfricanAmerican |
2.693600E-01 |
| Normal-vs-Asian |
3.335200E-01 |
| Caucasian-vs-AfricanAmerican |
2.20309999999779E-05 |
| Caucasian-vs-Asian |
9.929000E-01 |
| AfricanAmerican-vs-Asian |
9.038300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.781200E-04 |
| Normal-vs-Female |
1.160120E-04 |
| Male-vs-Female |
7.992600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.541600E-01 |
| Normal-vs-Age(41-60Yrs) |
3.244200E-04 |
| Normal-vs-Age(61-80Yrs) |
3.159700E-04 |
| Normal-vs-Age(81-100Yrs) |
3.062000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.293800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.330600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.818400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.752200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.421800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.122800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.755300E-03 |
| Normal-vs-Grade 2 |
9.21590026514707E-10 |
| Normal-vs-Grade 3 |
2.113500E-02 |
| Normal-vs-Grade 4 |
4.978800E-01 |
| Grade 1-vs-Grade 2 |
6.246600E-01 |
| Grade 1-vs-Grade 3 |
1.823970E-01 |
| Grade 1-vs-Grade 4 |
3.677400E-01 |
| Grade 2-vs-Grade 3 |
5.982900E-04 |
| Grade 2-vs-Grade 4 |
1.763970E-01 |
| Grade 3-vs-Grade 4 |
9.074600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.66333613549341E-12 |
| Normal-vs-ccB subtype |
6.608200E-01 |
| ccA subtype-vs-ccB subtype |
1.7990997580597E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.835930E-04 |
| Normal-vs-N1 |
4.284200E-01 |
| N0-vs-N1 |
6.543400E-01 |
|
|
